Search Results 361-370 of 15333 for CLL

  1. Clinical trials - Oncology (Medical)

    Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia ... Venetoclax is FDA approved for the treatment of CLL and SLL. The drug ...

  2. Clinical trials - Oncology (Medical)

    Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia ... Venetoclax is FDA approved for the treatment of CLL and SLL. The drug ...

  3. Clinical trials - Oncology (Medical)

    Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia ... Venetoclax is FDA approved for the treatment of CLL and SLL. The drug ...

  4. Clinical trials - Oncology (Medical)

    ... chronic lymphocytic leukemia (CLL). Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment.

  5. Medical Research & Education - Mayo Clinic News Network

    This episode of "Tomorrow's Cure" explores how a type of blood cancer, chronic lymphocytic leukemia (CLL), is hard to detect early in its development and ...

  6. Clinical trials - Oncology (Medical)

    Clinical trials · A Study of APG-2575 Alone or in Combination with Other Therapeutic Agents to Treat Relapsed and/or Refractory Chronic Lymphocytic Leukemia (CLL)/ ...

  7. Clinical trials - Oncology (Medical)

    Clinical trials · A Study of APG-2575 Alone or in Combination with Other Therapeutic Agents to Treat Relapsed and/or Refractory Chronic Lymphocytic Leukemia (CLL)/ ...

  8. Kay L. Medina, Ph.D. - Mayo Clinic Faculty Profiles

    ... chronic lymphocytic leukemia (CLL). Dr. Medina's lab recently showed that patients with CLL have impaired bone marrow hematopoiesis and significant ...

  9. Lisocabtagene maraleucel (intravenous route) - Side effects & uses - Mayo Clinic

    Lisocabtagene maraleucel injection is also used to treat chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) in patients who have ...

  10. Clinical trials - Oncology (Medical)

    Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. Durvalumab is FDA approved for treatment in lung ...